Updated on 15 June 2026
Seeking input on NHS pilot-readiness evidence
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
About
I’m looking for practical input from people who understand regulated innovation, NHS adoption, clinical safety, standards, AI assurance, procurement, evidence generation or healthtech commercialisation.
The question I’m working through is:
What evidence makes staff-facing medicines workflow software credible before a controlled NHS pilot?
Specific input I would value:
• intended-use wording
• safe product boundary
• source provenance expectations
• medicines identity and terminology risks
• standards language
• DCB0129/DCB0160 readiness thinking
• DTAC evidence planning
• IG, DPIA and data minimisation route
• AI governance and human review
• procurement route
• pilot evaluation metrics
• what NHS innovation teams actually trust
This is not a request for endorsement. It is a request for honest, practical challenge from people who can help make the pilot route safer, clearer and more credible.
Organisation
Similar opportunities
Project cooperation
PHARMORIS pilot-readiness cooperation: evidence, standards and NHS adoption
- Market Access
- Strategic Partnership
- Dissemination project results
Varun Cruz
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Partnership
Strategic partners for medicines workflow pilot-readiness
- Other
- Research
- Business
- Joint development
- Testing of technology
Varun Cruz
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Expertise
Evidence-led healthtech, medicines workflow and pilot-readiness
Varun Cruz
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom